About
Bit Bio develops a platform to create any human cell type from induced pluripotent stem cells (iPSCs) with precision and scalability for research and drug discovery applications.
Explore Bit Bio Limited's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.